Toward Noninvasive Diagnosis of IgA Nephropathy: A Pilot Urinary Metabolomic and Proteomic Study

Table 1

Clinical and laboratory data for patients with renal diseases.

Dg		S-urea; (mmol/L)	S-Cr; (µmol/L)	PU; (g/d)	PU; (g/L)	Age; (yrs)	M/F	eGFR; (mL/s/1.73 m^2)	U-Cr; (mmol/L)
IgAN	11						10/1
MN	2						1/1
LN	2						1/1
DN	2						0/2
ANCA	2						1/1

Dg, diagnosis; IgAN, IgA nephropathy; MN, membranous nephropathy; LN, lupus nephritis; DN, diabetic nephropathy; ANCA, antineutrophilic cytoplasmic antibody vasculitis-associated kidney disease; , number of patients; S-urea, concentration of serum urea; S-Cr, serum creatinine; PU, proteinuria; yrs, years; M/F, male/female; eGFR, estimated glomerular filtration rate (MDRD formula); U-Cr, urinary creatinine. Data are shown as mean values ± SD.